These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31269923)

  • 1. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.
    Drabe CH; Sørensen SS; Rasmussen A; Perch M; Gustafsson F; Rezahosseini O; Lundgren JD; Ostrowski SR; Nielsen SD
    BMC Infect Dis; 2019 Jul; 19(1):573. PubMed ID: 31269923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review.
    Rezahosseini O; Møller DL; Knudsen AD; Sørensen SS; Perch M; Gustafsson F; Rasmussen A; Ostrowski SR; Nielsen SD
    Front Immunol; 2020; 11():567715. PubMed ID: 33178194
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune monitoring after pediatric liver transplantation - the prospective ChilSFree cohort study.
    Goldschmidt I; Karch A; Mikolajczyk R; Mutschler F; Junge N; Pfister ED; Möhring T; d'Antiga L; McKiernan P; Kelly D; Debray D; McLin V; Pawlowska J; Hierro L; Daemen K; Keil J; Falk C; Baumann U
    BMC Gastroenterol; 2018 May; 18(1):63. PubMed ID: 29769027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in toll-like receptor ligand-induced cytokine concentrations before and after solid organ transplantation: A prospective, observational cohort study in a clinical setting.
    Møller DL; Sørensen SS; Perch M; Gustafsson F; Hald A; Knudsen AD; Abdulovski R; Arentoft NS; Lundgren J; Rasmussen A; Ostrowski SR; Nielsen SD
    Scand J Immunol; 2024 Feb; 99(2):e13337. PubMed ID: 38168873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
    Abdel-Wahab N; Safa H; Abudayyeh A; Johnson DH; Trinh VA; Zobniw CM; Lin H; Wong MK; Abdelrahim M; Gaber AO; Suarez-Almazor ME; Diab A
    J Immunother Cancer; 2019 Apr; 7(1):106. PubMed ID: 30992053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up.
    Møller DL; Sørensen SS; Perch M; Gustafsson F; Rezahosseini O; Knudsen AD; Scheike T; Knudsen JD; Lundgren J; Rasmussen A; Nielsen SD
    Clin Microbiol Infect; 2022 Mar; 28(3):391-397. PubMed ID: 34325067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation.
    Rezahosseini O; Drabe CH; Sørensen SS; Rasmussen A; Perch M; Ostrowski SR; Nielsen SD
    Transplant Rev (Orlando); 2019 Jul; 33(3):137-144. PubMed ID: 30981537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
    van Gent R; Metselaar HJ; Kwekkeboom J
    Transplant Rev (Orlando); 2017 Apr; 31(2):78-86. PubMed ID: 28131494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells: first steps of clinical application in solid organ transplantation.
    van der Net JB; Bushell A; Wood KJ; Harden PN
    Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus infections among children receiving a solid organ transplant: clinical features, epidemiology, and antimicrobial susceptibility.
    McNeil JC; Munoz FM; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2015 Feb; 17(1):39-47. PubMed ID: 25573269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence.
    Dendle C; Mulley WR; Holdsworth S
    Transplant Rev (Orlando); 2019 Apr; 33(2):87-98. PubMed ID: 30551846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of recipients of both bone marrow and solid organ transplants. A review.
    Dey B; Sykes M; Spitzer TR
    Medicine (Baltimore); 1998 Sep; 77(5):355-69. PubMed ID: 9772924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and risk factors of infections after solid organ transplantation.
    Muñoz P; Fernández NS; Fariñas MC
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():10-8. PubMed ID: 22542030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients at a Midwestern Center.
    George IA; Santos CA; Olsen MA; Bailey TC
    Transplantation; 2016 May; 100(5):1073-8. PubMed ID: 26950719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".
    Roberts MB; Fishman JA
    Clin Infect Dis; 2021 Oct; 73(7):e1302-e1317. PubMed ID: 32803228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of immunoglobulin use in solid organ transplant recipients: protocol for a systematic review and meta-analysis.
    Cowan J; Hutton B; Fergusson N; Bennett A; Tay J; Cameron DW; Knoll GA
    Syst Rev; 2015 Nov; 4():167. PubMed ID: 26585506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.
    Slepicka PF; Yazdanifar M; Bertaina A
    Front Immunol; 2021; 12():688460. PubMed ID: 34177941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding the right time for weaning off immunosuppression in solid organ transplant recipients.
    Orlando G
    Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.